Trials / Terminated
TerminatedNCT00386750
Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function
An Open-label, Single-center Study of the Effects of Co-artemether, Atovaquone-proguanil, and Artesunate-mefloquine on Auditory Function Following the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in Patients 12 Years of Age or Older.
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 265 (planned)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
THIS STUDY IS NOT ENROLLING PATIENTS IN THE USA. To evaluate the effects of artemether/ lumefantrine on the auditory function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Artemether-lumefantrine |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2006-10-12
- Last updated
- 2012-04-27
Source: ClinicalTrials.gov record NCT00386750. Inclusion in this directory is not an endorsement.